Cargando…
YB-1 modulates the drug resistance of glioma cells by activation of MDM2/p53 pathway
BACKGROUND: Y-box-binding protein-1 (YB-1) is aberrantly expressed in a variety of cancers. However, the biological functional role of YB-1 in glioma is not yet clear. METHODS: The expression of MDM2 and YB-1 was analyzed by real time PCR. Overexpression and knockdown of YB-1 in glioma cells were cr...
Autores principales: | Tong, Hui, Zhao, Kai, Zhang, Jingyu, Zhu, Jinxin, Xiao, Jianqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338113/ https://www.ncbi.nlm.nih.gov/pubmed/30679904 http://dx.doi.org/10.2147/DDDT.S185514 |
Ejemplares similares
-
The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013) -
Evolution of the p53-MDM2 pathway
por: Åberg, Emma, et al.
Publicado: (2017) -
The RP-Mdm2-p53 Pathway and Tumorigenesis
por: Miliani de Marval, Paula L., et al.
Publicado: (2011) -
FOXN3 inhibits cell proliferation and invasion via modulating the AKT/MDM2/p53 axis in human glioma
por: Wang, Chaojia, et al.
Publicado: (2021) -
Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
por: Traweek, Raymond S., et al.
Publicado: (2022)